SCHEMBL14877461

SCHEMBL14877461

C=CCOC(=O)C1CCCC(Br)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP3A4 P08684 1/20 0.33
TLR4 O00206 1/20 0.33
TSHR P16473 3/20 0.32
TP53 P04637 2/20 0.32
POLB P06746 1/20 0.32
MAPK1 P28482 1/20 0.32
RECQL P46063 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
HSD17B10 Q99714 1/20 0.30
NPC1 O15118 1/20 0.30
MAPT P10636 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1617437 0.81 TLR4 (0.49) GAAALDH1A1TLR4SMN1; SMN2NPSR1
SCHEMBL8020503 0.81 TSHR (0.35) GAAALDH1A1CYP3A4TLR4TSHR
SCHEMBL2721962 0.78 TSHR (0.36) GAAALDH1A1CYP3A4TLR4TSHR
SCHEMBL22468826 0.78 TSHR (0.36) GAAALDH1A1CYP3A4TLR4TSHR
SCHEMBL29529763 0.78 TSHR (0.36) GAAALDH1A1CYP3A4TLR4TSHR
SCHEMBL6475425 0.76 MCL1 (0.41) GAAALDH1A1CYP3A4TLR4TSHR
SCHEMBL8744677 0.75 CA1 (0.35) GAAALDH1A1CYP3A4TSHRTP53
SCHEMBL10588700 0.75 GAA (0.34) GAAALDH1A1CYP3A4TLR4TSHR
SCHEMBL11782843 0.75 CYP1A2 (0.38) ALDH1A1TLR4MAPK1SMN1; SMN2KDM4E
SCHEMBL10231781 0.74 ALDH1A1 (0.35) GAAALDH1A1CYP3A4TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329254-B2 Process for the preparation of 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide and intermediates thereof AOP ORPHAN PHARMACEUTICALS AG (AT) 2019-06-25 US disclosed
US-20160304455-A1 PROCESS FOR THE PREPARATION OF 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE AND INTERMEDIATES THEREOF AOP ORPHAN IP AG (LI) 2016-10-20 US disclosed
US-20140303382-A1 PROCESS FOR THE PREPARATION OF 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE AND INTERMEDIATES THEREOF SIENA BIOTECH S.P.A. (IT) 2014-10-09 US disclosed
EP-2768807-A1 PROCESSES FOR THE PREPARATION OF 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE AND OF ITS PRECURSORS Siena Biotech S.p.A. (IT) 2014-08-27 EP disclosed
CN-103958467-A Process for preparing 6-chloro-2, 3,4, 9-tetrahydro-1H-carbazole-1-carboxamide and precursors thereof SIENA BIOTECH SPA 2014-07-30 CN disclosed
WO-2013057258-A1 PROCESSES FOR THE PREPARATION OF 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE AND OF ITS PRECURSORS SIENA BIOTECH S.P.A. (IT) 2013-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140303382-A1 PROCESS FOR THE PREPARATION OF 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE AND INTERMEDIATES THEREOF CYP2B6, CYP2D6, CYP2C9 GAA 2173/4885ALDH1A1 276/4885CYP3A4 5/4885
US-10329254-B2 Process for the preparation of 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide and intermediates thereof CYP2B6, CYP2D6, CYP2C9 GAA 2173/4885ALDH1A1 276/4885CYP3A4 5/4885
US-20160304455-A1 PROCESS FOR THE PREPARATION OF 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE AND INTERMEDIATES THEREOF CYP2B6, CYP2D6, CYP2C9 GAA 2173/4885ALDH1A1 276/4885CYP3A4 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.